Compare PHAR & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHAR | CGBD |
|---|---|---|
| Founded | 1988 | 2012 |
| Country | Netherlands | United States |
| Employees | N/A | 2500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 885.7M | 742.2M |
| IPO Year | 2020 | N/A |
| Metric | PHAR | CGBD |
|---|---|---|
| Price | $12.87 | $10.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 8 |
| Target Price | ★ $38.33 | $12.92 |
| AVG Volume (30 Days) | 10.9K | ★ 522.1K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 14.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.04 | $3.74 |
| Revenue Next Year | $2.51 | $1.80 |
| P/E Ratio | $3,041.22 | ★ $10.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.54 | $10.50 |
| 52 Week High | $21.34 | $14.32 |
| Indicator | PHAR | CGBD |
|---|---|---|
| Relative Strength Index (RSI) | 40.62 | 39.62 |
| Support Level | $11.84 | N/A |
| Resistance Level | $13.61 | $11.10 |
| Average True Range (ATR) | 0.41 | 0.23 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 43.22 | 26.83 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.